Editorial: Emerging trends in moyamoya disease: diagnostic and therapeutic innovations - Takeaways - MDSpire

Editorial: Emerging trends in moyamoya disease: diagnostic and therapeutic innovations

  • By

  • Shihao He

  • Hansen Chen

  • Rong Wang

  • Yuanli Zhao

  • May 29, 2026

  • 0 min

Share

  • 1

    Moyamoya disease is characterized by chronic stenosis or occlusion of internal carotid arteries and fragile collateral networks.

  • 2

    Recent advances in diagnosis and treatment of moyamoya disease integrate novel imaging, serum biomarkers, and mechanistic studies.

  • 3

    Surgical strategies for moyamoya disease must be tailored to individual anatomical and clinical factors, emphasizing a configurable approach.

  • 4

    Temporal muscle thickness measured on preoperative MRI may predict post-operative motor aphasia in moyamoya disease patients.

  • 5

    Asymptomatic moyamoya disease is not benign, with a systematic review revealing significant clinical implications during follow-up.

Original Source(s)

Editorial: Emerging trends in moyamoya disease: diagnostic and therapeutic innovations

  • by Shihao He, Hansen Chen, Rong Wang, Yuanli Zhao

  • May 29, 2026

Related Content

Lateralized glymphatic system impairment in acute ischemic stroke: a DTI–ALPS study of upper limb motor function

Cardiac intimal sarcoma presenting as basilar artery occlusion treated with tenecteplase and thrombectomy: a case report

Endovascular thrombectomy in patients with acute ischemic stroke and prestroke mRS 3: a multicenter IPTW analysis focused on functional preservation